Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
HeartSciences Inc. (HSCS)
Company Research
Source: GlobeNewswire
Southlake, TX, Jan. 29, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), today announced that Cibolo Rural Health Networks (“Cibolo Health”) has selected MyoVista Insights™ as its endorsed ECG management platform for independent hospitals within its high-value networks. This collaboration will provide Cibolo Health’s network of 123 independent hospitals across six states with access to a modern, cloud-native ECG management platform designed to improve workflow efficiency, data accessibility, and clinical decision-making. Through this partnership, HeartSciences will support Cibolo Health in enabling its member hospitals to modernize legacy ECG workflows, allowing physicians to interpret ECGs more quickly and efficiently without disrupting existing clinical proces
Show less
Read more
Impact Snapshot
Event Time:
HSCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HSCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HSCS alerts
High impacting HeartSciences Inc. news events
Weekly update
A roundup of the hottest topics
HSCS
News
- University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference CenterGlobeNewswire
- HeartSciences (NASDAQ:HSCS) had its price target raised by analysts at Ascendiant Capital Markets from $9.00 to $9.20. They now have a "buy" rating on the stock.MarketBeat
- Heart Test Laboratories reports Q2 results [Seeking Alpha]Seeking Alpha
- HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business UpdateGlobeNewswire
- HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ DeviceGlobeNewswire
HSCS
Analyst Actions
- 12/22/25 - Ascendiant Capital
HSCS
Sec Filings
- 1/16/26 - Form 8-K
- 1/12/26 - Form 4
- 1/12/26 - Form 4
- HSCS's page on the SEC website